Judge strikes Merck witness testimony ATLANTIC CITY, New Jersey (Reuters)

Judge strikes Merck witness testimony
ATLANTIC CITY, New Jersey (Reuters) - The judge in the second Vioxx trial on Friday ordered that the testimony of Merck & Co. Inc.'s first defense witness be stricken from the record, saying he overstepped his role as a fact witness.

Uterine cancer may raise ovarian cancer risk
NEW YORK (Reuters Health) - As many as one quarter of young women with uterine cancer also have ovarian cancer, new research suggests.

Web sales of bird flu drug spark counterfeit fears
ZURICH (Reuters) - Swiss drug maker Roche urged consumers on Friday not to buy its flu drug Tamiflu over the Internet to avoid the risk of purchasing potentially counterfeit pills as they build stockpiles in case of a bird flu pandemic.

Hodgkin's survivors at risk for breast cancer
NEW YORK (Reuters Health) - Due to the chest radiation that is often given for treatment, women who survive Hodgkin's disease are at heightened risk for breast cancer. In fact, in some survivors, the odds of developing breast cancer are as high as 40 percent, new research indicates.